Yong Feng Wang

Validation in China of a non‐invasive salivary pepsin biomarker containing two unique human pepsin monoclonal antibodies to diagnose gastroesophageal reflux disease

J. Zhong, X. Shen, Chang-qing Yang, 2019, Journal of digestive diseases.

Tolvaptan in Chinese cirrhotic patients with ascites: A randomized, placebo‐controlled phase 2 trial

Zheng Wang, H. Ding, Jun Cheng, 2018, Journal of digestive diseases.